Our Leadership Team

Ali Akhai

Chairman

Mr. Ali Akhai is the current Chairman of the Martin Dow Group.

After completing his Bachelor of Science business graduate degree (BSc) from Brunel University in the UK, he proceeded to further his education with a double Masters degree.The first was a Master of Science from University of Hertfordshire, UK in Global Business followed by Master of Science from Novancia Business School, France in International Business Development & Consulting.In 2016, Ali returned to Pakistan and joined the family business of Martin Dow Group of Companies. He went through a structured orientation program covering Marketing, Finance, Business Development, HR & Regulatory affairs. In 2017, he took on the mantle of Business Development “lead” and launched 8 new products for the Group by mid 2018.Over the past 2 years at Martin Dow Group, Ali has been trained and groomed by his father and Founding Chairman Mr. M. Jawed Akhai and has played his part in the leadership team that successfully acquired the majority shareholding of Merck (Pvt) Ltd in 2016.

Leadership Team

Javed Ghulam Mohammad

Group Managing Director & CEO

Mr. Javed is a qualified fellow member of the Institute of Cost & Management Accountants of Pakistan. His professional journey spreads over 25 years during which he has worked in diversified functions on several key positions at leading multinational as well as national companies.Mr. Javed started his pharmaceutical career from Abbott Laboratories and continued his journey of excellence in Getz Pharma, Martin Dow and Briogene. Over the first 17 years of his professional experience, he has been leading Finance, Marketing, International Business, Business Development, Supply Chain, Regulatory Affairs, New Product Development and Technical functions.He served Martin Dow as Managing Director from August 2010 till October 2012 after the acquisition of Roche brands and manufacturing facility. Then he moved to Briogene and worked there as Chief Executive Officer (CEO) for over 2 years.For the last 4 years, he has been associated with AJ Research & Pharma (subsidiary of Al Jomaih group, Saudi Arabia) based in Malaysia as Chief Executive Officer (CEO). Under his leadership, AJ Pharma has progressed tremendously from a startup company to operations in more than 7 countries of ASEAN region and a business base in GCC markets. He managed a diversified team in AJ Pharma to establish a strong presence in both prescription based and consumer health markets of ASEAN and GCC.

Alain Schwenck

Site Director

Alain has worked in senior positions at various multinational pharmaceutical companies in France; starting with Rhone Poulenc® and then Lilly France®, LFB®, BMS® and Genethon®. Alain’s experience covers the fields of aseptic filling and freeze-drying, plasma fractionation, dry forms and bio production for clinical and manufacturing and commercial operations in Europe, US and Japan.

Perrine Carrez

Quality Director

Perrine joined Martin Dow Pharmaceuticals in August 2019. Perrine worked with AJC Pharma Laboratory where she held positions of increasing responsibility, Quality Control Manager, Head of Pharmaceutical Affairs, then Industrial Manager and Chief Pharmacist between 2007 and 2019.